Velindre University NHS Trust was pleased to welcome the Chief Medical Officer for Wales for a visit that provided a comprehensive look at the broad work across the Trust and the progress being made on the new Velindre Cancer Centre.
Velindre Cancer Service colleagues have been recognised for their outstanding contributions to healthcare innovation at last week’s MediWales Innovation Awards.
Accession Therapeutics’ ATTEST trial is a first-in-human Phase 1 trial in solid tumour patients, testing TROCEPT-01 (also known as ATTR-01). The trial is being delivered by Velindre University NHS Trust and Cardiff and Vale University Health Board.
Emma Williams, Senior Research Nurse Manager at the Velindre Cancer Service, has become the first nurse to be accepted onto the Cancer Research UK Women in Influence programme.
We issued a statement on 28 November regarding the departure of David Donegan from the organisation. The Trust has been clear that it will not comment on individual employment matters.
Llongyfarchiadau to Ashley, Carlie and Michele!